The Dermatology CRO for Biotech, Powered by Technology

Delivering faster, better, cheaper dermatology trial results for biotech sponsors.

Our dermatology CRO Executive Team

Our Dermatology CRO team's expertise spans across indications with prior experience at both large and small CROs

Our experienced CRO executive team works closely with our expert site operations team to continuously review execution strategies, closely monitor patient recruitment efforts, and mitigate key study risks for Dermatology clinical trials.

Powered By Our Connected Technology Platform

The Vial Technology Platform leverages connected systems and intuitive design to run global trials efficiently at scale

A diagram of an oncology healthcare technology platform.
A diagram of the oncology technology platform.

Vial’s modern technology platform brings clinical trials out of the paper stone age, allowing for streamlined processes inside one end-to-end system.

no-nonsense pricing

Vial offers sponsors fixed-pricing agreements with no change orders — ever.

A line icon of a dollar sign and a price tag representing the cost of oncology services provided by a Contract Research Organization (CRO).

Flat-rate pricing

A fixed-fee pricing model guarantees a set budget for the entirety of a project, regardless of the time and expense that accrues.

Two arrows pointing in different directions, representing conflicting perspectives.

Zero change orders

Thorough planning, an experienced team, and our next-gen technology platform allow us to proactively prepare for and avert common errors or delays.

An oncology icon with gears and a warning sign.

Risk-share on commitments

We focus on delivering results that matter, and our risk share on commitments approach underscores our dedication to your trial's success.

Fast Start-up and Consolidated Site Activation

Vial’s Site Startup Platform enables sites to seamlessly onboard to our trials

The Result: Self-service onboarding eliminating administrative burden and increasing progress transparency.

Scientific Advisory Board

Experience across Dermatology

Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance research.

Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City
Senior physician of Pariser Dermatology Specialist and Principal Investigator
Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School
Chief Development Officer at Evelo Biosciences
Pediatric Dermatologist at Pediatric Dermatology of Miami
Professor and Chair of Dermatology, Residency Program Director of Translational Research, and Director of Supportive Oncodermatology at George Washington University

vial dedicated phase I unit

Vial’s Dermatology Phase 1 unit provides a unified full service solution to early clinical development

Phase 1 Units are critical to advancing care and validating treatments, which is why it is essential to have a dependable Phase 1 unit you can rely on.

Vial’s dedicated Phase 1 research coordinators have upwards of 25 years of experience and are IATA and CPR certified. All of our research coordinators complete annual GCP and NIH training, as well as routine in-house training. In addition to extensive training, they are familiar with multiple EDC and IRT/IWRS systems, making them a well-rounded team you can trust.

A scientist in a lab coat holding a pink liquid, engaged in scientific research or analysis.
500+
Dermatology Clinical Trials
10,000+
Randomized Patients
A scientist in a lab coat holding a pink liquid, engaged in scientific research or analysis.

Discover insights to help you run trials faster and more efficiently.

Articles

Patient Recruitment in 2023: What Works and What Doesn’t in Clinical Trial Enrollment

Events / January 8-11, 2024 / San Francisco, CA

Vial will be at the 42nd Annual J.P. Morgan Healthcare Conference

Whitepapers

A Closer Look at Value-Based Healthcare in Oncology

Podcast

First in Human Episode #44 featuring Max Darnell

Articles

AI-Designed Drugs vs. Traditional Drug Discovery: Pros and Cons

Podcast

First in Human Episode #38 featuring Stephen Doyle

Advancing dermatology Care

Dermatological conditions can have a significant impact on patients' quality of life.

Clinical trials are critical for developing new treatments and advancing care for patients with dermatological conditions, which affect their physical appearance, causing discomfort and pain, and impacting mental health. Vial offers dermatology sponsors solutions that enable them to improve the efficiency of their clinical trials and accelerate the development of effective therapies. By improving patient outcomes and quality of life, Vial CRO's support contributes to advancing dermatology research and treatment options.

A man and woman collaborating on a computer, engaged in a productive work session.
A man and woman collaborating on a computer, engaged in a productive work session.

Connect with us.

Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.